Laurion Capital Management LP Harpoon Therapeutics, Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $1.74 Million - $2.4 Million	-305,954 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $2.56 Million - $4.54 Million	-324,617 Reduced 51.48%	305,954 $2.42 Million
Q2 2021 Aug 13, 2021	BUY	$13.81 - $23.25 $2.72 Million - $4.59 Million	197,271 Added 45.53%	630,571 $8.75 Million
Q1 2021 May 14, 2021	BUY	$17.65 - $24.16 $7.65 Million - $10.5 Million	433,300 New	433,300 $9.07 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.